Memiontec eyes doubling market cap by 2026 with sights set on regional expansion
DeeperDive is a beta AI feature. Refer to full articles for the facts.
WATER treatment company Memiontec had a rough start as a listed company, launching its initial public offering (IPO) on the Singapore Exchange in February 2020 – just as the Covid-19 pandemic was unravelling.
In a recent interview with The Business Times, Memiontec’s chief executive Tay Kiat Seng recalled how the company had to cut its public float and settle for a lower price-to-earnings ratio because of poor market conditions and cautious investor sentiment. The group had also been hoping for a public float of 20 to 25 per cent, but was forced to trim this to 17 to 20 per cent.
Tay said the company “bit the bullet” and forged ahead with the listing anyway. But its problems did not end there, as the company’s order book and demand for its offerings were hit.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025